Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mariyah Mahmood"'
Autor:
Mariyah Mahmood, Andrew Maurice
Publikováno v:
InnovAiT: Education and inspiration for general practice. 15:675-677
Autor:
Mari C. Vazquez-Borrego, Rio-Moreno Mercedes Del, Magdalena Wnek, Mariyah Mahmood, Jose Cordoba-Chacon, Michelle Puchowicz, Rhonda Kineman
Publikováno v:
Endocrine Abstracts.
Autor:
Mercedes del Rio-Moreno, Shoshana Yakar, Mariyah Mahmood, Natalie Pelke, Papasani V. Subbaiah, Mari C Vazquez-Borrego, Jose Cordoba-Chacon, Andre Sarmento-Cabral, Grace Guzman, Elena Gutierrez-Casado, Rhonda D. Kineman
Publikováno v:
J Endocrinol
A reduction in hepatocyte growth hormone (GH)-signaling promotes non-alcoholic fatty liver disease (NAFLD). However, debate remains as to the relative contribution of the direct effects of GH on hepatocyte function vs indirect effects, via alteration
Autor:
Andre Sarmento-Cabral, Grace Guzman, Jose Cordoba-Chacon, Mariyah Mahmood, Shoshana Yakar, Mercedes del Rio-Moreno, Papasani V. Subbaiah, Rhonda D. Kineman, Mari C Vazquez-Borrego, Elena Gutierrez-Casado
Publikováno v:
Journal of the Endocrine Society
GH dysregulation contributes to the development of non-alcoholic fatty liver disease (NAFLD), however debate remains as to the relative contribution of the direct vs indirect effects of GH, via IGF1. Mouse models with congenital, liver-specific knock
Autor:
Mari C Vazquez-Borrego, Andre Sarmento-Cabral, Grace Guzman, Mercedes del Rio-Moreno, Jose Cordoba-Chacon, Rhonda D. Kineman, Papasani V. Subbaiah, Mariyah Mahmood
Publikováno v:
Journal of the Endocrine Society
Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of pathologies ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) that can lead to cirrhosis and hepatocellular carcinoma. Clinical and mouse studies indicate GH-signa
Autor:
Rhonda D. Kineman, Maria del Carmen Vazquez Borrego, Mariyah Mahmood, Shoshana Yakar, Andre Sarmento-Cabral, Michelle Puchowicz, Mercedes del Rio Moreno, Jose Cordoba-Chacon, Papasani V. Subbaiah
Publikováno v:
Journal of the Endocrine Society
A reduction in GH, as well as IGF1, is associated with non-alcoholic fatty liver disease (NAFLD). However, the relative contribution of changes in circulating GH and IGF1, to hepatic triglyceride accumulation (steatosis), remains to be clearly define
Publikováno v:
Rheumatology. 53:i173-i174